BILLS-109hr1290ih.pdf

1290 annually 1996 1998 2001 8 year 1ST SESSION H. R. 1290 every 2 years MARCH 14, 2005 1 months later than 90 days each of fiscal years 2007 1997 2002 each year fiscal year 2004 later than October 1 7 2010 biennial later than 12 months fiscal year 2006 October 1

the ‘‘VA the ‘VA’ the ‘‘Hepatitis C Epidemic 4 Control and Prevention Act

1290 IH the United States United States States New Mexico VA the United States of America New York 16 States

icans Americans Indian

HCV SEC the National Institutes of Health U.S.C. Congress Advisory Board State National Institutes National Institutes of Health the Public Health Service Act Disease Control and Prevention Control and Prevention APPROPRIATIONS C Epidemic Control and Prevention Act the ‘Advisory Board’ THE HOUSE OF REPRESENTATIVES the Liver Disease Research Action Plan the Liver Disease Research Action The Advisory Board Federal Register the Centers for Disease Control 19 Food and Drug Administration Health Federal the Liver Disease Research Advisory Board United the Public Health Service the Health Insurance the ‘NIDDK’ the National Institute of Diabe- 4 tes LIVER DISEASE RESEARCH ADVISORY BOARD Services Administration House of Representa- SEROPREVALENCE Development Conferences the Department of 22 the Centers for Disease Control the Centers for Disease 7 Control and Prevention sory Board Control of Hepatitis C Virus (HCV the Centers for Disease Control and Prevention VA the Centers for Disease The Department of Veterans Affairs the National Institutes of 8) Conservative EPIDEMIOLOGY the Hepatitis C Resource Center Centers

MCNULTY ABERCROMBIE ROS-LEHTINEN BERMAN DOGGETT WILSON MCGOVERN MEEKS PAYNE OWENS

hepatitis infected virus infection prevention control liver prevention disease referral medical control chronic epidemic act direct tested